Argan (AGX) Got Higher Lake Street Rating; Crispr Therapeutics Aghares (CRSP) Shorts Down By 12.18%

March 28, 2018 - By Winifred Garcia

Crispr Therapeutics Aghares (NASDAQ:CRSP) had a decrease of 12.18% in short interest. CRSP’s SI was 1.25 million shares in March as released by FINRA. Its down 12.18% from 1.42M shares previously. With 941,400 avg volume, 1 days are for Crispr Therapeutics Aghares (NASDAQ:CRSP)’s short sellers to cover CRSP’s short positions. The SI to Crispr Therapeutics Aghares’s float is 6.65%. The stock decreased 14.53% or $7.595 during the last trading session, reaching $44.675. About 1.58 million shares traded or 41.84% up from the average. CRISPR Therapeutics AG (NASDAQ:CRSP) has risen 144.93% since March 28, 2017 and is uptrending. It has outperformed by 133.38% the S&P500.

Among 3 analysts covering Argan (NYSE:AGX), 0 have Buy rating, 1 Sell and 2 Hold. Therefore 0 are positive. Argan has $56 highest and $45 lowest target. $50.50’s average target is 32.20% above currents $38.2 stock price. Argan had 4 analyst reports since October 16, 2015 according to SRatingsIntel. Avondale downgraded the stock to “Mkt Perform” rating in Thursday, December 8 report. Wm Smith initiated it with “Not Rated” rating and $45 target in Friday, October 16 report. The firm earned “Buy” rating on Thursday, June 9 by Lake Street. The stock of Argan, Inc. (NYSE:AGX) has “Hold” rating given on Thursday, December 7 by Lake Street.

The stock decreased 1.42% or $0.55 during the last trading session, reaching $38.2. About 118,192 shares traded. Argan, Inc. (NYSE:AGX) has declined 40.73% since March 28, 2017 and is downtrending. It has underperformed by 52.28% the S&P500.

Argan, Inc., through its subsidiaries, provides engineering, procurement, construction, commissioning, activities management, maintenance, development, technical, and consulting services to the power generation and renewable energy markets. The company has market cap of $593.96 million. The company's Power Industry Services segment offers engineering, procurement, and construction contracting services to the owners of alternative energy facilities, such as biomass plants, wind farms, and solar fields; and design, construction, start-up, and operation services for approximately 76 facilities with approximately 14,500 megawatts of power-generating capacity. It has a 7.11 P/E ratio. This segment serves independent power project owners, public utilities, power plant equipment suppliers, and global energy plant construction firms.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: